Two ICREA spin offs obtain funding from H2020 SME support instrument. The entrepreneurs Laura Soucek (ICREA at VHIO) and Roger Gomis (ICREA at IRB) have both secured a bunch of money from H2020 SME instrument this week. Their two companies are attacking different aspects of cancer tumors. Inbiomotion, Roger’s company is testing a platform to prevent breast cancer from invading bone marrow. Peptomyc, Laura’s company, has invented an innovative mollecule that blocks one of the most critical oncogenes, applicable to a wide array of different tumors.
Congratulations Laura and Roger, and keep up the good work!
More details? Click here.
OTHER NEWS
Premio ‘Fundación Real Academia de Ciencias al Joven Talento Científico Femenino 2024’
La Profesora de Investigación ICREA María Escudero Escribano (ICN2) recibe el premio en la categoría de Física, Química y Ciencias…
5 ICREAs amongst the 1% most cited researchers of 2024 worldwide
Congratulations to all of them, and also to their host institutions for this well deserved recognition. · Josep Dalmau (FRCB-IDIBAPS)…